Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.24.1.1.u2
Income Taxes
12 Months Ended
Mar. 31, 2023
Income Taxes  
Income Taxes

8. Income Taxes

Loss before provision for income taxes consisted of the following for the years ended March 31, 2023 and 2022 (in thousands):

Year Ended March 31,

 

    

2023

    

2022

 

United States

$

(24,560)

$

(22,391)

Foreign

    

 

45

    

 

40

Loss before provision for income taxes

$

(24,515)

$

(22,351)

Current income tax provision is the amount of income taxes reported or expected to be reported on our income tax return. The provision for current income taxes was $7,000 and $19,000 for the years ended March 31, 2023 and March 31, 2022, respectively. The current income taxes were related to state income and foreign taxes. The Company did not have current federal income taxes for the fiscal years ended March 31, 2023 and March 31, 2022.

Actual income tax expense differed from the amount computed by applying statutory corporate income tax rates to loss from operations before income taxes. A reconciliation of income tax (benefit) expense to the federal statutory rate follows (in thousands):

Year Ended March 31,

 

    

2023

    

2022

 

Federal income tax benefit at the statutory rate

$

(5,148)

$

(4,694)

State taxes, net of federal effect

    

 

(1,837)

    

 

(714)

Foreign taxes

 

 

5

Expiring NOLs and tax credits

10,156

11,028

Impact of state rate change

 

107

 

(142)

Valuation allowance

 

(3,532)

 

(5,552)

Shortfall in tax benefit—stock compensation

 

262

 

75

True-up

(5)

Other

 

4

 

13

Income tax expense

$

7

$

19

The Company’s deferred tax assets and liabilities consisted of the following at March 31, 2023 and 2022 (in thousands):

    

Year Ended March 31,

2023

    

2022

Deferred tax assets:

Inventories

$

3,456

$

2,194

Warranty reserve

 

3,140

 

2,513

Bad debt reserve

1,217

199

Deferred revenue

 

2,385

 

2,284

Net operating loss (“NOL”) carryforwards

 

126,180

 

130,928

Tax credit carryforwards

 

12,686

 

13,370

Depreciation, amortization and impairment loss

 

496

 

Lease liability

 

2,113

 

1,464

Interest limitation

 

6,330

 

4,655

Other

 

1,279

 

1,095

Deferred tax assets

 

159,282

 

158,702

Valuation allowance for deferred tax assets

 

(153,171)

 

(156,702)

Deferred tax assets, net of valuation allowance

 

6,111

 

2,000

Deferred tax liabilities:

Depreciation, amortization and impairment loss

 

(3,998)

 

(594)

Right of use assets

 

(2,113)

 

(1,406)

Net deferred tax assets

$

$

Because of the uncertainty surrounding the timing of realizing the benefits of favorable tax attributes in future income tax returns, the Company has placed a valuation allowance against its net deferred income tax assets. The change in valuation allowance for fiscal years ended March 31, 2023 and 2022 was $3.5 million and $5.5 million, respectively.

The Company’s NOL and tax credit carryforwards for federal and state income tax purposes at March 31, 2023 were as follows (in thousands):

Expiration

    

Amount

    

Period

 

Federal NOL generated before April 1, 2018

$

449,151

 

2023 - 2038

Federal NOL generated after March 31, 2018

$

89,643

 

Indefinite

State NOL

$

185,650

 

2025 - 2039

Federal tax credit carryforwards

$

5,029

 

2023 - 2038

State tax credit carryforwards

$

9,692

 

Indefinite

The NOLs and federal and state tax credits can be carried forward to offset future taxable income, if any. Utilization of the NOLs and tax credits are subject to an annual limitation of approximately $57.3 million due to the ownership change limitations provided by the Internal Revenue Code of 1986 and similar state provisions. The federal tax credit carryforward is a research and development credit, which may be carried forward. The state tax credits consist of a research and development credit can be carried forward indefinitely.

Accounting Standards Codification (“ASC”) 740, Income Taxes clarifies the accounting for income taxes by prescribing a minimum recognition threshold that a tax position is required to meet before being recognized in the financial statements. ASC 740 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on management’s evaluation, the total amount of unrecognized tax benefits related to research and development credits as of March 31, 2023 and 2022 was $1.9 million. There were no interest or penalties related to unrecognized tax benefits as of March 31, 2023 or March 31, 2022. The amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate as of March 31, 2023 and 2022 was $1.9 million. However, this impact would be offset by an equal increase in the deferred tax valuation allowance as the

Company has recorded a full valuation allowance against its deferred tax assets because of uncertainty as to future realization. The fully reserved recognized federal and state deferred tax assets related to research and development credits balance as of March 31, 2023 and 2022 was $5.0 million and $9.7 million, and $5.7 million and $9.7 million, respectively.

A reconciliation of the beginning and ending amount of total gross unrecognized tax benefits is as follows (in thousands):

Balance at March 31, 2021

$

1,946

Gross increase related to prior year tax positions

 

Gross increase related to current year tax positions

 

Lapse of statute of limitations

 

(48)

Balance at March 31, 2022

$

1,898

Gross increase related to prior year tax positions

 

Gross increase related to current year tax positions

 

Lapse of statute of limitations

 

(42)

Balance at March 31, 2023

$

1,856

The Company does not expect a material change to its unrecognized tax benefits over the next twelve months.

The Company files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state, local or non-U.S. income tax examinations by tax authorities for the years before 2017. However, net operating loss carryforwards remain subject to examination to the extent they are carried forward and impact a year that is open to examination by tax authorities. The Company's evaluation was performed for the tax years which remain subject to examination by major tax jurisdictions as of March 31, 2023. When applicable, the Company accounts for interest and penalties generated by tax contingencies as interest and other expense, net in the statements of operations.